Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 IriSys Opens Biz Development Office in Shanghai | Contract Pharma

What are you searching for?

Sign in
Breaking News

IriSys Opens Biz Development Office in Shanghai

Will help Asian companies gain access to U.S. markets

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Custom pharmaceutical development and manufacturing company IriSys has established a business development office in Shanghai. The office is staffed by business development manager, Leonard Shi.

IriSys says it has implemented a strategy to focus on Asia, bridging the gap between innovators there and access to the U.S. regulatory infrastructure and markets.

“In addition to our capabilities in formulation and novel drug delivery techniques, our FDA consulting services will be of great value to small to mid-sized Japanese and Chinese pharmaceutical companies that want to bring products to the U.S. for development,” said Gerald Yakatan, founder, chairman and chief executive officer, IriSys. “Our Shanghai office will help us develop business opportunities in China, Japan and other Asian countries.”

IriSys was a finalist in the 2015 MetroConnect competition and the $25,000 in award monies contributed to this effort. The MetroConnect Prize is the flagship program of the Go Global San Diego Initiative that provides small and medium-sized enterprises (SMEs) the resources they need to engage in global markets.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics